Regulation of lymphoid versus myeloid fate 'choice' by the transcription factor Mef2c

被引:100
作者
Stehling-Sun, Sandra [1 ]
Dade, Jessica [2 ]
Nutt, Stephen L. [3 ]
DeKoter, Rodney P. [2 ]
Camargo, Fernando D. [1 ]
机构
[1] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA
[2] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA
[3] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia
基金
美国国家卫生研究院;
关键词
B-CELL DEVELOPMENT; HEMATOPOIETIC PROGENITORS; SELF-RENEWAL; BONE-MARROW; C/EBP-ALPHA; STEM-CELLS; PU.1; EXPRESSION; ENHANCER; GENE;
D O I
10.1038/ni.1694
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Despite advances in the identification of lymphoid-restricted progenitor cells, the transcription factors essential for their generation remain to be identified. Here we describe an unexpected function for the myeloid oncogene product Mef2c in lymphoid development. Mef2c deficiency was associated with profound defects in the production of B cells, T cells, natural killer cells and common lymphoid progenitor cells and an enhanced myeloid output. In multipotent progenitors, Mef2c was required for the proper expression of several key lymphoid regulators and restriction of the myeloid fate. Our studies also show that Mef2c was a critical transcriptional target of the transcription factor PU.1 during lymphopoiesis. Thus, Mef2c is a crucial component of the transcriptional network that regulates cell fate 'choice' in multipotent progenitors.
引用
收藏
页码:289 / 296
页数:8
相关论文
共 40 条
[1]   Upregulation of flt3 expression within the bone marrow Lin-Sca1+c-kit+ stem cell compartment is accompanied by loss of self-renewal capacity [J].
Adolfsson, J ;
Borge, OJ ;
Bryder, D ;
Theilgaard-Mönch, K ;
Åstrand-Grundström, I ;
Sitnicka, E ;
Sasaki, Y ;
Jacobsen, SEW .
IMMUNITY, 2001, 15 (04) :659-669
[2]   A clonogenic common myeloid progenitor that gives rise to all myeloid lineages [J].
Akashi, K ;
Traver, D ;
Miyamoto, T ;
Weissman, IL .
NATURE, 2000, 404 (6774) :193-197
[3]   MEF2C transcription factor controls chondrocyte hypertrophy and bone development [J].
Arnold, Michael A. ;
Kim, Yuri ;
Czubryt, Michael P. ;
Phan, Dillon ;
McAnally, John ;
Qi, Xiaoxia ;
Shelton, John M. ;
Richardson, James A. ;
Bassel-Duby, Rhonda ;
Olson, Eric N. .
DEVELOPMENTAL CELL, 2007, 12 (03) :377-389
[4]   Hematopoietic stem cells do not engraft with absolute efficiencies [J].
Camargo, FD ;
Chambers, SM ;
Drew, E ;
McNagny, KM ;
Goodell, MA .
BLOOD, 2006, 107 (02) :501-507
[5]   The importance of PU.1 concentration in hematopoietic lineage commitment and maturation [J].
Dahl, R ;
Simon, MC .
BLOOD CELLS MOLECULES AND DISEASES, 2003, 31 (02) :229-233
[6]   PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis [J].
Dakic, A ;
Metcalf, D ;
Di Rago, L ;
Mifsud, S ;
Wu, L ;
Nutt, SL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (09) :1487-1502
[7]   Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer [J].
De Val, S ;
Anderson, JP ;
Heldt, AB ;
Khiem, D ;
Xu, SM ;
Black, BL .
DEVELOPMENTAL BIOLOGY, 2004, 275 (02) :424-434
[8]   PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors [J].
DeKoter, RP ;
Lee, HJ ;
Singh, H .
IMMUNITY, 2002, 16 (02) :297-309
[9]   Regulation of B lymphocyte and macrophage development by graded expression of PU.1 [J].
DeKoter, RP ;
Singh, H .
SCIENCE, 2000, 288 (5470) :1439-1441
[10]   E2A proteins promote development of lymphoid-primed multipotent progenitors [J].
Dias, Sheila ;
Mansson, Robert ;
Gurbuxani, Sandeep ;
Sigvardsson, Mikael ;
Kee, Barbara L. .
IMMUNITY, 2008, 29 (02) :217-227